Focus: Conavi Medical is a Toronto-based biotechnology company specializing in robotic surgical technologies for cardiovascular interventions. The company is developing the Novasight Hybrid System for coronary artery disease treatment.
Profile data last refreshed 22m ago · AI intelligence enriched 2w ago
Conavi Medical is an early-stage surgical robotics play with clinical potential but carries execution risk typical of pre-revenue biotech; suitable only for risk-tolerant candidates with cardiac intervention expertise.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Conavi Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Conavi Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles